Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.25
Ask: 1.35
Change: 0.055 (4.49%)
Spread: 0.10 (8.00%)
Open: 1.225
High: 1.28
Low: 1.28
Prev. Close: 1.225
AEX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE ON TANZANIA TRANSACTIONS

1 Feb 2016 07:00

RNS Number : 5470N
Aminex PLC
01 February 2016
 

 

Aminex plc

 

UPDATE ON TANZANIA TRANSACTIONS

 

Aminex PLC ("Aminex" or "the Company") advises that the proposed disposal of a 25% interest in the Kiliwani North Development Licence and a 50% interest in the Ruvuma PSA to Bowleven PLC, announced to shareholders on 19 November 2015, will not proceed. In discussions during the due diligence process, a forward work programme could not be agreed which would be acceptable to Aminex, its lender, the Tanzanian authorities and Solo Oil plc ("Solo").

 

As a consequence, the contingent agreement between Solo and Aminex for a transfer of a 12.5% in the Ruvuma PSA interest is no longer applicable and the partners will maintain their existing interests.

 

Aminex will retain its existing interests as follows:

 

· 55.575% (operator) interest in the Kiliwani North Development Licence, for which LR Senergy has ascribed 28 BCF contingent (2C) resources (gross) and which is about to come on-stream following the signing of a Gas Sales Agreement in January; and

· 75% (operator) interest in the Ruvuma PSA, where it is making progress towards the recompletion of the Ntorya 1 discovery well, and the drilling of the Ntorya 2 appraisal well. This programme has been designed with the support of TPDC to fast-track the field development and potentially build an early production system for local power demand.

 

Aminex CEO, Jay Bhattacherjee, commented: "The recent completion of the gas sales arrangements for the Kiliwani North field opens a new chapter for Aminex in Tanzania. With the commencement of first production from the Kiliwani North 1 well, we expect to book our first reserves in-country. The Company continues to focus on appraising Ntorya where we have planned an exciting programme prior to applying for a 25 year development licence. Aminex is currently assessing alternative ways to monetise its gas in the Ruvuma PSA acreage, where we already have a commercial gas discovery at Ntorya-1, through an early production system."

 

For further information:

 

Aminex PLC

+44 20 7291 3100

Jay Bhattacherjee, Chief Executive Officer

Max Williams, Chief Financial Officer

 

Corporate Brokers

Shore Capital Stockbrokers-Jerry Keen

+44 20 7408 4090

Davy Corporate Finance-Brian Garrahy

+35 3 1679 7788

 

Yellow Jersey PR (Financial PR)

 

+44 7768 537 739

Dominic Barretto

Aidan Stanley

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLUAUVRNRAAOAR
Date   Source Headline
28th Mar 20222:05 pmRNSSecond Price Monitoring Extn
28th Mar 20222:00 pmRNSPrice Monitoring Extension
2nd Feb 20227:00 amRNSRuvuma Operations Update
28th Jan 20222:06 pmRNSSecond Price Monitoring Extn
28th Jan 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
7th Jan 20221:30 pmRNSDirector/PDMR Shareholding
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
2nd Dec 20217:00 amRNSRuvuma Operations Update
18th Nov 20217:00 amRNSReceipt of Kiliwani North Gas Receivables
22nd Oct 202110:00 amRNSRuvuma Operations Update
15th Oct 20212:00 pmRNSPayment of Kiliwani North Gas Receivables
30th Sep 20217:00 amRNS2021 Half-Yearly Report
28th Sep 20214:40 pmRNSSecond Price Monitoring Extn
28th Sep 20214:37 pmRNSPrice Monitoring Extension
24th Sep 20217:00 amRNSAward of Seismic Acquisition Contract
18th Aug 202111:05 amRNSSecond Price Monitoring Extn
18th Aug 202111:00 amRNSPrice Monitoring Extension
18th Aug 202110:00 amRNSExtension of Ruvuma Licence
29th Jul 20213:04 pmRNSResult of AGM
28th Jul 20217:00 amRNSDirectorate Change and Update on AGM
7th Jul 20217:00 amRNSNotice of AGM
30th Jun 20215:17 pmRNSRuvuma Operations Update
30th Jun 20215:15 pmRNSFinal Results
28th May 20214:37 pmRNSUpdate to Annual Report and Accounts deadline
29th Apr 20214:36 pmRNSPrice Monitoring Extension
29th Apr 20217:00 amRNSExtension to Annual Report and Accounts deadline
1st Apr 202111:05 amRNSSecond Price Monitoring Extn
1st Apr 202111:00 amRNSPrice Monitoring Extension
29th Mar 20219:05 amRNSSecond Price Monitoring Extn
29th Mar 20219:00 amRNSPrice Monitoring Extension
26th Mar 20212:05 pmRNSSecond Price Monitoring Extn
26th Mar 20212:00 pmRNSPrice Monitoring Extension
26th Mar 202111:05 amRNSSecond Price Monitoring Extn
26th Mar 202111:00 amRNSPrice Monitoring Extension
25th Mar 20214:41 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
25th Mar 20212:05 pmRNSSecond Price Monitoring Extn
25th Mar 20212:00 pmRNSPrice Monitoring Extension
11th Mar 20214:48 pmRNSUpdate on migration of shares from CREST
11th Mar 20214:41 pmRNSSecond Price Monitoring Extn
11th Mar 20214:35 pmRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSRuvuma Operations Update
18th Feb 20211:06 pmRNSResult of EGM
29th Jan 20217:00 amRNSStrategic and Corporate Update
27th Jan 20217:00 amRNSNotice of EGM
26th Jan 202110:00 amRNSDirectorate Change
7th Jan 202111:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.